These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 7561078)

  • 1. Rapid rejection of H2k and H2k/b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice.
    Davenport C; Kumar V; Bennett M
    J Immunol; 1995 Oct; 155(8):3742-9. PubMed ID: 7561078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells.
    Davenport C; Haile A; Kumar V; Bennett M
    J Immunol; 1995 Mar; 154(6):2568-77. PubMed ID: 7876533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of newborn liver cells as a murine model for cord blood cell transplantation.
    Davenport C; Kumar V; Bennett M
    J Immunol; 1993 Aug; 151(3):1597-605. PubMed ID: 8101544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.
    Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M
    J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts.
    Sentman CL; Kumar V; Koo G; Bennett M
    J Immunol; 1989 Mar; 142(6):1847-53. PubMed ID: 2646375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells.
    Murphy WJ; Kumar V; Cope JC; Bennett M
    J Immunol; 1990 May; 144(9):3305-11. PubMed ID: 2329274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a role for T cell receptors (TCR) in the effector phase of acute bone marrow graft rejection. TCR V beta 5 transgenic mice lack effector cells able to cause graft rejection.
    Kikly K; Dennert G
    J Immunol; 1992 Dec; 149(11):3489-94. PubMed ID: 1431119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
    Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh-1 determinant 2 shared by H-2d and H-2f.
    Sentman CL; Kumar V; Bennett M
    Eur J Immunol; 1991 Nov; 21(11):2821-8. PubMed ID: 1718761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts.
    Yankelevich B; Knobloch C; Nowicki M; Dennert G
    J Immunol; 1989 May; 142(10):3423-30. PubMed ID: 2654290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
    Dennert G; Anderson CG; Warner J
    J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
    George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
    J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice.
    Nagata S; Okano S; Yonemitsu Y; Nakagawa K; Tomita Y; Yoshikai Y; Shimada M; Maehara Y; Sueishi K
    Transplantation; 2006 Sep; 82(5):689-98. PubMed ID: 16969294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation.
    Murphy WJ; Bennett M; Kumar V; Longo DL
    J Immunol; 1992 May; 148(9):2953-60. PubMed ID: 1573278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.